论文部分内容阅读
《中国生化药物杂志》于1976年创刊,一直秉承“基础与临床结合、普及与提高并重”的原则,报道有关生化药物的基础与临床研究最新进展,并以“促进我国生化药物医学的健康发展及深化国际学术合作与交流”为己任。本刊目前为中文核心期刊;被《美国化学文摘》、《中国生物学文摘》、《中国药学文摘》等重要检索系统收录;其主管单位是无锡日报报业集团,主办单位是无锡锡报期刊传媒有限公司;由《中国生化药物杂志》编辑部和北京数字医视文化传媒有限公司出版发行。本刊的国际标准刊号ISSN 1005-1678,国
“Chinese Journal of Biochemical Drugs” was founded in 1976, has been adhering to the “basic and clinical combination of universal and improve both” principle, report on the basic progress of biochemical drugs and clinical research, and “to promote biochemical medicine in China Healthy development and deepen international academic cooperation and exchange ”as its own responsibility. The journal is currently in Chinese core journals; it has been collected by important search systems such as “American Chemical Abstracts,” “Chinese Biology Digest,” and “Chinese Pharmaceutical Digest.” Its supervisor is Wuxi Daily Newspaper Group, Media Co., Ltd .; published by China Editorial Department of Biochemical Drugs and Beijing Digital Medical Culture Media Co., Ltd. This issue of international standard serial number ISSN 1005-1678, the country